Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 08/14/14 → 06/22/17 |
Funding
- Novartis Pharmaceuticals Corporation: $42,938.02
Open-Label, Single-Arm Extension Study to the Double-Blind, Randomized, Multicenter, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 0.5 mg FTY720 Administered Orally Once Daily Versus Placebo in Patients.....
- Coyle, Patricia (PI)
- Kaufmann, Tara (CoPI)
- Kowalska, Agnieszka (CoPI)
- Sibony, Patrick (CoPI)
- Vlay, Stephen (CoPI)
Project: Research